Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amit K Verma
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
508 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Saint Helena Hospital
St. Helena, California, United States
- Presbyterian Intercommunity Hospital
Whittier, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2009
- Primary completion
- 8 Jul 2019
- Completion
- 2 Oct 2026
- Last update posted
- 29 May 2026
- Registered enrollment
- 247
- Registry id
- NCT00843882
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.